The AAPS and Catalent Applied Drug Delivery Institute Partner on the 3rd Annual Global Academic Competition for Life Science Leaders of Tomorrow

Competition Aimed at Top Pharmacy & Life Sciences Universities to Encourage Academic Research and Accelerate Drug Delivery Application

SOMERSET, NJ, January 23, 2014 – The Catalent Applied Drug Delivery Institute in collaboration with the American Association of Pharmaceutical Scientists (AAPS) have announced details of the "3rd Annual Global Academic Competition for Life Science Leaders of Tomorrow". The program, which aims to encourage students' interest and increase their knowledge of applied drug delivery technologies, is now open for entries via

The competition welcomes entries from eligible global university students enrolled in graduate programs focused on the pharmaceutical sciences, industrial pharmacy, drug delivery, drug development or related disciplines. Participating students will compete for one of five prizes of $2,000, a complimentary, one-year AAPS membership, and the opportunity to have their submissions published by Catalent in the Institute and/or industry publications. Entries should take the form of an original review article based on topics such as drug development, improving therapeutic profiles and bioavailability, pre-formulation, drug delivery innovation in inhalation, biologics, lipid-based systems, crossing the blood-brain barrier, or on the delivery of drugs in certain patient groups such as pediatrics.  The deadline for entries is March 28th, 2014.

"The Global Academic Competition supports the mission of The Catalent Applied Drug Delivery Institute to foster education, collaboration, and adoption of drug delivery technologies to develop better treatments for patients," stated Terry Robinson, Executive Director of the Institute.  "We are delighted that AAPS is co-sponsoring the competition this year, and with their reach to 2,500 student and postdoctoral Fellow members, and almost 100 student chapters in 35 countries around the globe, we look forward to expanding the number of participating universities." 

"The AAPS Awards Program provides a wonderful opportunity for scientists and students to be recognized and honored for their valuable contributions to the pharmaceutical sciences," said John Lisack, Jr., CAE, AAPS executive director. "We are thrilled to collaborate with the Catalent Drug Delivery Institute again this year to award future leaders in the industry."

Participating universities in the US include, St. John's, Rutgers, New Jersey Institute of Technology, and University of North Carolina at Chapel Hill. In Europe, participating universities include Saarland and Düsseldorf, Germany and Bath and Bristol in the U.K.

Details of the Global Academic Competition including entry forms and the official contest rules can be found at

About AAPS

The American Association of Pharmaceutical Scientists is a professional, scientific association of approximately 11,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to serve the public and enhance their contributions to health. Visit today.

About the Catalent Applied Drug Delivery Institute

Catalent's Applied Drug Delivery Institute was founded to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments and foster industry collaboration on major issues pertaining to drug development, formulation and delivery. It is pursuing a multi-tiered approach of seed funding, strategic counsel, and educational programs to advance the adoption of emerging technologies. Visit:

About Catalent

Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products.  With over 75 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in Fiscal 2013 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.